These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1924168)

  • 1. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.
    Sinko PJ; Leesman GD; Amidon GL
    Pharm Res; 1991 Aug; 8(8):979-88. PubMed ID: 1924168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications.
    Sinko PJ; Leesman GD; Amidon GL
    Pharm Res; 1993 Feb; 10(2):271-5. PubMed ID: 8456076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model.
    Oh DM; Curl RL; Amidon GL
    Pharm Res; 1993 Feb; 10(2):264-70. PubMed ID: 8456075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
    Rinaki E; Valsami G; Macheras P
    Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biowaivers among Class II drugs: theoretical justification and practical examples.
    Rinaki E; Dokoumetzidis A; Valsami G; Macheras P
    Pharm Res; 2004 Sep; 21(9):1567-72. PubMed ID: 15497681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.
    Kalampokis A; Argyrakis P; Macheras P
    Pharm Res; 1999 Nov; 16(11):1764-9. PubMed ID: 10571284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.
    Amidon GL; Sinko PJ; Fleisher D
    Pharm Res; 1988 Oct; 5(10):651-4. PubMed ID: 3244618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physiologic model for simulating gastrointestinal flow and drug absorption in rats.
    Willmann S; Schmitt W; Keldenich J; Dressman JB
    Pharm Res; 2003 Nov; 20(11):1766-71. PubMed ID: 14661920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link between drug absorption solubility and permeability measurements in Caco-2 cells.
    Pade V; Stavchansky S
    J Pharm Sci; 1998 Dec; 87(12):1604-7. PubMed ID: 10189274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compartmental absorption and transit model for estimating oral drug absorption.
    Yu LX; Amidon GL
    Int J Pharm; 1999 Sep; 186(2):119-25. PubMed ID: 10486429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination.
    Kou JH; Fleisher D; Amidon GL
    Pharm Res; 1991 Mar; 8(3):298-305. PubMed ID: 2052515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans.
    Chiang PC; Liu J; Fan P; Wong H
    J Pharm Sci; 2018 Jul; 107(7):1798-1805. PubMed ID: 29574230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration.
    Chiou WL
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):474-82. PubMed ID: 7820330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical model for dose-dependent drug absorption.
    Dressman JB; Fleisher D; Amidon GL
    J Pharm Sci; 1984 Sep; 73(9):1274-9. PubMed ID: 6548523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.